Perceptive Advisors »

Evommune shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $10M 448k 22.99

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Celcuity (CELC)
Ascendis Pharma A/s Sponsored Adr (ASND)
Roivant Sciences SHS (ROIV)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Rhythm Pharmaceuticals (RYTM)
Spyre Therapeutics Com New (SYRE)
Nuvalent Inc-a (NUVL)
Edgewise Therapeutics (EWTX)
Protagonist Therapeutics (PTGX)
Apogee Therapeutics (APGE)
Travere Therapeutics (TVTX)
Amylyx Pharmaceuticals (AMLX)
Immatics SHS (IMTX)
Relay Therapeutics (RLAY)

View all positions for Perceptive Advisors

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
MPM Oncology Impact Management
Nan Fung Group Holdings
Rtw Investments
SymBiosis Capital Partners
Marshall Wace
Eventide Asset Management
Henderson Group
Baker Bros. Advisors
Alyeska Investment Group
BlackRock
Kynam Capital Management

View all funds holding Evommune